Adjuvants are commonly utilised to enhance the efficacy of a vaccine and thereby help increase the resulting immune response in a patient.
Our industry-leading technology can create nanoparticles with controlled droplet sizes and distribution curves that can be sterile filtered with minimal yield losses.
Vaccine adjuvants - our High Pressure Homogenizers
Easy to scale-up - from Lab R&D to full production systems - up to 2000 l/h - with repeatable results.
Controllable, industry-leading pressures up to 4200 bar (60,000 psi / 420 MPa).
Multiple options for temperature control including pre-heating and rapid post process cooling.
CIP and SIP capability. Provision of DQ / IQ /OQ documentation.
Easy to clean and sterilize.
Easy to maintain with low ongoing ownership costs.
Precise high shear creating smaller, target particles with a narrow size distribution.